Clinical trial
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With…
NCT00171054 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171054 |
|---|---|
| Title | Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension |
| Official title | A Randomized, Double-blind, Parallel Group, Active-controlled, 38-week Study to Evaluate the Efficacy of Valsartan Versus Amlodipine on the Arterial Properties of Postmenopausal Women With Mild to Moderate Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan 320 mg, Amlodipine 10 mg, Hydrochlorothiazide |
| Enrollment | 125 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 6, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: